MEDICINA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICINA
Largest movements
- Receivables within one year +€20,712
up €20,712 (+37.6%), from €55,047 to €75,759
- Cash +€17,602
up €17,602 (+176.3%), from €9,982 to €27,584
mainly Net result for the year (+€62,755) and Depreciation (+€5,896)
- Receivables after one year +€15,000
up €15,000 (+60.0%), from €25,000 to €40,000
- Profit (loss) carried forward +€62,755
up €62,755 (+72.5%), from €86,568 to €149,323
- Tax, wage and social debts -€10,500
down €10,500 (-75.0%), from €14,000 to €3,500
- Other debts +€1,762
up €1,762 (+164.4%), from €1,072 to €2,834
- Gross operating margin -€24,548
down €24,548 (-22.3%), from €110,259 to €85,711
- Taxes -€5,946
down €5,946 (-25.9%), from €23,001 to €17,055
- Depreciation +€5,276
up €5,276 (+850.0%), from €621 to €5,896
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €104,140 | €158,158 | +€54,017 | +51.9% |
| Fixed assets | 21/28 | €13,879 | €14,414 | +€535 | +3.9% |
| Tangible fixed assets | 22/27 | €13,879 | €14,414 | +€535 | +3.9% |
| Furniture and vehicles | 24 | €13,879 | €14,414 | +€535 | +3.9% |
| Current assets | 29/58 | €90,261 | €143,744 | +€53,483 | +59.3% |
| Amounts receivable after more than one year | 29 | €25,000 | €40,000 | +€15,000 | +60.0% |
| Other amounts receivable | 291 | €25,000 | €40,000 | +€15,000 | +60.0% |
| Amounts receivable within one year | 40/41 | €55,047 | €75,759 | +€20,712 | +37.6% |
| Trade receivables | 40 | €55,047 | €75,759 | +€20,712 | +37.6% |
| Cash at bank and in hand | 54/58 | €9,982 | €27,584 | +€17,602 | +176.3% |
| Deferred charges and accrued income | 490/1 | €232 | €401 | +€169 | +72.7% |
| Total equity and liabilities | 10/49 | €104,140 | €158,158 | +€54,017 | +51.9% |
| Equity | 10/15 | €89,068 | €151,823 | +€62,755 | +70.5% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €86,568 | €149,323 | +€62,755 | +72.5% |
| Amounts payable | 17/49 | €15,072 | €6,334 | -€8,738 | -58.0% |
| Amounts payable within one year | 42/48 | €15,072 | €6,334 | -€8,738 | -58.0% |
| Taxes, remuneration and social security | 45 | €14,000 | €3,500 | -€10,500 | -75.0% |
| Taxes | 450/3 | €14,000 | €3,500 | -€10,500 | -75.0% |
| Other amounts payable | 47/48 | €1,072 | €2,834 | +€1,762 | +164.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €621 | €5,896 | +€5,276 | +850.0% |
| Other operating charges | 640/8 | €40 | €58 | +€18 | +45.0% |
| Gross operating margin | 9900 | €110,259 | €85,711 | -€24,548 | -22.3% |
| Operating profit (loss) | 9901 | €109,598 | €79,757 | -€29,842 | -27.2% |
| Financial income | 75/76B | €5 | €127 | +€122 | +2628.7% |
| Recurring financial income | 75 | €5 | €127 | +€122 | +2628.7% |
| Financial charges | 65/66B | €34 | €73 | +€39 | +114.7% |
| Recurring financial charges | 65 | €34 | €73 | +€39 | +114.7% |
| Profit (loss) for the period before taxes | 9903 | €109,569 | €79,810 | -€29,759 | -27.2% |
| Income taxes | 67/77 | €23,001 | €17,055 | -€5,946 | -25.9% |
| Profit (loss) for the period | 9904 | €86,568 | €62,755 | -€23,813 | -27.5% |
| Profit (loss) for the period to be appropriated | 9905 | €86,568 | €62,755 | -€23,813 | -27.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.